Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

COVID-19 may harm male fertility and damage the reproductive system.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Anabolic steroid users may face higher risk of severe COVID-19.

Social media data can help track and predict COVID-19 symptoms and trends.

Insulin resistance linked to obesity may increase COVID-19 severity.

The treatment might help COVID-19 related hair loss, but more research is needed.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

Testosterone may influence COVID-19 severity and outcomes.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Testosterone's effects on COVID-19 are unclear and need more research.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Some drugs may help treat both COVID-19 and radiation injury.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.